TNDM Stock Analysis: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$22.32
-0.25 (-1.11%)
âŧ
5d:
-1.76%
30d:
+32.07%
90d:
+41.62%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TNDM is fairly priced but lacks strong directional signals. At -17.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TNDM is fairly priced but lacks strong directional signals. At -17.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $22.32, which is considered slightly high relative to its 30-day fair value range of $16.92 to $22.42. From a valuation perspective, the stock is trading at a discount (Forward PE: 128.6) compared to its historical average (224.6). Remarkably, the market is currently pricing in an annual earnings decline of 17.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $21.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TNDM scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.70 (+27.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $21.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TNDM scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.70 (+27.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$16.92 -
$22.42
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.9%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.2% below Wall St target ($28.70)
- WARNING: Composite score 36/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.92 -
$22.42
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$21.70
Resistance Level
$24.81
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
128.60
Wall Street Target
$28.70
(+27.2%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
-37.0%
Profit Margin
-6.1%
Valuation Discount vs History
-17.0% cheaper
PE vs Historical
128.6 vs 224.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.0%
(market-implied from PE analysis)
1-Year Target
$20.31
(-10%)
2-Year Target
$18.28
(-19%)
3-Year Target
$16.45
(-27%)
3-Yr Target (if PE normalizes)
(PE: 129â225)
$28.74
(+27%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 128.6 to 224.6
Stabilization Target:
$39.42
(+74.6%)
PE Expansion Potential:
+74.6%
Share & Embed Analysis
Last updated: August 22, 2026 6:12 PM ET
Data refreshes hourly during market hours. Next update: 7:12 PM
Data refreshes hourly during market hours. Next update: 7:12 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark David Novara
SELL
187 shares
2026-03-17
Mark David Novara
SELL
2 shares
2026-03-05
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
